Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
To guide our collaborative, globe-spanning alliance, GA4GH relies on a Standards Steering Committee and an Executive Committee.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across four Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Solve your real-world data problems with support from this valuable network of global institutions.
Work with like-minded groups committed to better data use in areas like rare disease, cancer, and infectious disease.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
10 Dec 2019
10 December is International Human Rights Day. For our first guest here on the OmicsXchange podcast produced by GA4GH, we are talking with Bartha Maria Knoppers — professor of human genetics and the director of the Center of Genomics and Policy at McGill University — on how Article 27 of the 1948 Universal Declaration of Human Rights is important for global genomic data sharing.
December 10 is International Human Rights Day. For our first guest here on the OmicsXchange Podcast produced by GA4GH, we are talking with Dr. Bartha Knoppers – professor of human genetics and the director of the Center of Genomics and Policy at McGill University – on how article 27 of the 1948 Universal Declaration of Human Rights is important for global genomic data sharing.
Angela Page: 71 years ago today, the United Nations General Assembly adopted the Universal Declaration of Human Rights. Today, we’re talking with Dr. Bartha Maria Knoppers, who is a professor of human genetics and the director of the Center of Genomics and Policy at McGill University. She holds a doctoral degree in comparative medical law from the University of Paris. Dr. Knoppers founded the Population Project in Genomics (P3G) and CARTAGENE, which is Quebec’s population biobank. She’s chaired multiple institutional ethics working groups, including those of the International Cancer Genome Consortium, the Thousand Genomes Project, the Human Cell Atlas, and, most notably to us, the Global Alliance for Genomics and Health Regulatory and Ethics Work Stream. This International Human Rights Day, we are speaking with Dr. Knoppers to learn more about how article 27 of the 1948 Universal Declaration of Human Rights is important for global genomic data sharing. Welcome, Dr. Knoppers! Why don’t you start us off by explaining what Article 27 actually says?
Dr. Bartha Maria Knoppers: Article 27 states that everyone has the right to freely participate in the cultural life of the community, to enjoy the arts and to share in scientific advancement and its benefits. It has a second article that’s often forgotten: Everyone has the right to the protection of the moral and material interest resulting from any scientific, literary, or artistic production of which he is the author. So this right has the right to science and the right to be recognized as an author and inventor. So in that sense, it balances the trust of science to make data freely available, at the same time recognize human inventiveness.
Angela Page: You have referred to it as a previously dormant right, Article 27. Can you explain why that is or why that was overlooked and how you dug it back up and dusted it off for this purpose?
Dr. Bartha Maria Knoppers: Yeah, I’ve been a law professor for 23 years before I moved to the Faculty of Medicine here at McGill University. And I took international law, I remember the declaration, but I don’t remember this article. And it was an article in Science Magazine published by the American Association for the Advancement of Science in June 2013, called a human right to science. I thought what? So I started digging, and I found out that this article 27 of the Declaration, which is a declaration of the United Nations, was actually adopted as an official—if I can use a non legal language—official International Covenant on Economic, Social and Cultural Rights in 1966. So I thought, wow, there’s this right in Article 15 of the covenant that looks like the exact wording of the article 27. And that was the purpose of the editorial in science and the AAAS was to start thinking, how can we activate this right – how can we go beyond ethics and national legislation? How could we make this a right that everyone can have the freedom of science, benefit from the science and be recognized for their contribution to the science.
Angela Page: So you noticed these multiple references to article 27, but was it being upheld in any way?
Dr. Bartha Maria Knoppers: So a colleague in Cambridge University Professor Rumiana Yotova and I decided to look at all the reports that when countries sign and ratify, they become a state party, they have to report every few years to the United Nations. What have they done to realize this right? So we started looking through reports and we didn’t find very much from since 1966. But then we started noticing around the 1990s when the internet became more widespread, references to data sharing, access to data, international collaboration with respect to data, and realized that this was actually could be the foundation for promoting the right of everyone to benefit from science. We found out that UNESCO in 2009 had already issued a statement called the Venice statement on the right to enjoy the benefits of scientific progress and its applications, and somehow that had laid dormant as well. So beginning there, we thought, let’s find a way to activate this right in a way that can be universally applicable.
Angela Page: You saw this article in 2013, which is the same year that GA4GH was founded – were those coincidental streams, or were you looking for it or…
Dr. Bartha Maria Knoppers: No, I was not looking for it. It was a eureka moment, let’s put it that way. And I thought, how do we make the Global Alliance for Genomics and Health—the GA4GH—how can we catapult it into a new way of thinking? And that’s why the Framework for the Responsible Sharing of Genomic and Health Related Data that was written for GA4GH, and part of its mission, part of its constitution, actually is founded on this dual right of freedom of science, slash benefit, and a recognition.
Angela Page: So you’ve shared this journey of Article 27, going from a dormant right to gaining more recognition within the scientific community. Do you feel that something’s changed, that the community is now starting to think about science in terms of this foundation of human rights?
Dr. Bartha Maria Knoppers: It’s coming along – it’s very slow. You know the law, give any – even a bill that you want to have become, give it 10 years. I was part of a Royal Commission on reproductive technologies – we had it in our report in 1993 in Canada, we didn’t see a law till 2004. I’m not saying that we need a law, what we need are of frameworks, policies, directives from governments from the European Commission and so on that start repeating this right, that start entering it in into common culture, common parlance.
Angela Page: So I’ve also heard you say that the benefits of data sharing outweigh the risks. Explain that a bit more for us.
Dr. Bartha Maria Knoppers: There are enough scandals of data leaks. There’s the Cambridge Analytica, there are huge monopolies on data and how data is shared and people have access to it. But I think that sort of phobic protectionism – presuming that people at all costs want privacy, and they may I mean, they may, with respect to not having their children photographed or not being subject to advertising without spam and the rest of it.
Angela Page: And we know these kinds of scandals are scary to the public; we all hear about people being hacked or having their personal data accessed without their permission. But I’m curious how sharing genomic data is maybe unique.
Dr. Bartha Maria Knoppers: I presume that most people want to have the benefits of sharing medical data and I say that because that medical data is about them, it’s about others, but it’s about human beings. And the more that we understand how our situation, our health slash disease state, fits into that of others, the more we can understand how to prevent and to treat. So I go from the opposite assumption. I don’t presume it’s risky. I presume it’s beneficial.
Angela Page: So given the benefits and risks, how do we enter data sharing into the “common parlance, common culture,” as you mentioned before? How do we address people’s concerns while also moving science forward?
Angela Page: Right, and that’s why the work of the Regulatory & Ethics work stream is so important. So as we work towards this goal, what are some of the remaining gaps in the world of responsible data sharing that the Regulatory & Ethics work stream will focus on going forward?
Dr. Bartha Maria Knoppers: Our primary challenge in the last year has been how do we serve as a motor to encourage researchers in Europe, who are now subject to the General Data Protection Regulation—very heavy handed approach to data security and data privacy And on the face of it, it could easily be interpreted to say, you need an explicit consent for everything. But if you do a proper reading of it, and a lot of the legal beagles in the GA4GH, as well as their bioethics colleagues, and so on, have started looking at it and saying, how do we interpret this in a way that does not make data go back to data hoarding, data silos? That was the way that the genomics community worked pretty well before the map of the human genome. How do we not lose the momentum of data sharing and continue to share internationally? I mean, it’s so important. And that brings me to the second big challenge. Does our health system have sufficient diversity in the genomic information it has access to, to be able to interpret a particular patient’s symptoms or prevent those symptoms, when most population reference databases are 81% Caucasian. So our second challenge after facing the General Data Protection Regulation and a seemingly restrictive approach to data sharing, is to integrate more diverse data into our databases to properly represent modern heterogeneous populations. Because we can’t ever achieve genomic medicine for all in a democratic sense, in a scientific sense, we can’t do proper genomic medicine if we don’t have that kind of diversity of data used in the clinical setting.
Angela Page: Well, thank you so much, Dr. Knoppers, this has really been a great conversation and we appreciate having you. This Human Rights Day, we want to remember that article 27, along with the rest of the Universal Declaration, includes ALL people. Regardless of health status, gender, race, country of origin, or any other factors, everyone everywhere has the right to benefit from scientific advancement, and to be recognized for their contribution.